190 related articles for article (PubMed ID: 11992304)
21. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
22. Long term hormone therapy for perimenopausal and postmenopausal women.
Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
[TBL] [Abstract][Full Text] [Related]
23. Association between estrogen replacement therapy and heart failure in postmenopausal women: A systematic review and meta-analysis.
Chen Z; Wu C; Huang Z
Prev Med; 2024 Apr; 181():107909. PubMed ID: 38382766
[TBL] [Abstract][Full Text] [Related]
24. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis.
Shah NR; Borenstein J; Dubois RW
Menopause; 2005; 12(6):668-78. PubMed ID: 16278609
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
Oger E; Scarabin PY
Drugs Aging; 1999 Jan; 14(1):55-61. PubMed ID: 10069408
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.
Varas-Lorenzo C; García-Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Perez-Gutthann S
Am J Epidemiol; 1998 Feb; 147(4):387-90. PubMed ID: 9508106
[TBL] [Abstract][Full Text] [Related]
28. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study.
Renoux C; Dell'Aniello S; Suissa S
J Thromb Haemost; 2010 May; 8(5):979-86. PubMed ID: 20230416
[TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy for cognitive function in postmenopausal women.
Hogervorst E; Yaffe K; Richards M; Huppert F
Cochrane Database Syst Rev; 2002; (3):CD003122. PubMed ID: 12137675
[TBL] [Abstract][Full Text] [Related]
31. Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis.
Adomaityte J; Farooq M; Qayyum R
Thromb Haemost; 2008 Feb; 99(2):338-42. PubMed ID: 18278183
[TBL] [Abstract][Full Text] [Related]
32. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
Shapiro S
Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
[TBL] [Abstract][Full Text] [Related]
33. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.
Humphrey LL; Chan BK; Sox HC
Ann Intern Med; 2002 Aug; 137(4):273-84. PubMed ID: 12186518
[TBL] [Abstract][Full Text] [Related]
34. Validation of a decision model for preventive pharmacological strategies in postmenopausal women.
Perreault S; Levinton C; Laurier C; Moride Y; Ste-Marie LG; Crott R
Eur J Epidemiol; 2005; 20(1):89-101. PubMed ID: 15756909
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
